Highdose chemotherapy with peripheral blood progenitor cell support in primary treatment of advanced ovarian cancer;Stammzellgestutzte hochdosischemotherapie (HDCT) in der primar- behandlung des fortgeschrittenen ovarialkarzinoms

Praxis

Volumn 88, Issue 12, 1999, Pages 507-512

  Mobus, V ^a   Von Schilling, C ^a   Kreienberg, R ^a   Wiesneth, M ^a   Bergmann, L ^a   Frickhofen, N ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

High dose chemotherapy; Ovarian cancer; Peripheral stem cell support

Indexed keywords

CARBOPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; MELPHALAN; PACLITAXEL; ANTINEOPLASTIC AGENT;

ADULT; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MEGADOSE; FEASIBILITY STUDY; HUMAN; MULTICENTER STUDY; OVARY CANCER; PERIPHERAL BLOOD STEM CELL; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; STEM CELL TRANSPLANTATION; AGED; CANCER STAGING; DOSE RESPONSE; DRUG ADMINISTRATION; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; MIDDLE AGED; OVARY TUMOR; PATHOLOGY;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEASIBILITY STUDIES; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS;

EID: 0033580350     PISSN: 16618157     EISSN: 16618165     Source Type: Journal    
DOI: None     Document Type: Review

References (20)